Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Shares Issued (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 6 years of Shares Issued data on record, last reported at $1.4 million in Q1 2025.

  • For Q1 2025, Shares Issued changed N/A year-over-year to $1.4 million; the TTM value through Sep 2025 reached $1.4 million, down 72.37%, while the annual FY2023 figure was $5.0 million, N/A changed from the prior year.
  • Shares Issued reached $1.4 million in Q1 2025 per CYCN's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $12.5 million in Q4 2021 and bottomed at $17000.0 in Q2 2022.
  • Average Shares Issued over 4 years is $2.7 million, with a median of $133000.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: surged 2600.0% in 2021, then plummeted 87.22% in 2022.
  • A 4-year view of Shares Issued shows it stood at $12.5 million in 2021, then plummeted by 99.86% to $17000.0 in 2022, then skyrocketed by 29170.59% to $5.0 million in 2023, then tumbled by 72.37% to $1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $1.4 million in Q1 2025, $5.0 million in Q4 2023, and $17000.0 in Q2 2022.